Pressure BioSciences' Q2 Revenues Climb 70 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that revenues for the second quarter increased 70 percent year over year, driven by grant revenues.

The South Easton, Mass.-based firm recorded $324,908 in revenues for the three months ended June 30. Revenues generated by its Pressure Cycling Technology came in at $224,384, up 18 percent from $190,686 a year ago. The company also posted $100,524 in grant revenues compared to none a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.